Selling Domantis to Glaxo looks like a great move. First they get the huge cash injection. Over a dollar per share in a 1.30 company. The company they sold uses PTDs technology. Glaxo has the muscle to get it to market faster and expand the label, at which time they will be paying royalties to PTD. Cant see a down side there. What are they going to do with all that money? I see some long suffering holders selling into the rise, big mistake IMHO.
PTD
unknown
Selling Domantis to Glaxo looks like a great move. First they...
Add to My Watchlist
What is My Watchlist?